the GEKKO study launched in 1-2016 as part of the NCT 3.0 program, the DARIO study (start 09/2016, study end 06/2020) and the LEO study recruiting since 12-2020, the latter with participants in the age group 30-49 as part of the NCT "Proof of Concept Trial" program.
The GEKKO study collaborates with numerous clinics and practices in the area, the LEO study is conducted in collaboration with the Interdisciplinary Endoscopy Center (IEZ) at the Medical Clinic of Heidelberg University Hospital.
Another focus of the division is risk-adapted prevention, a working group headed by Prof. Mahdi Fallah.